MYCN and neoplasm: A recent international review of 8,800 patients throughout 1990–2002 confirmed patient age at diagnosis, tumor stage, DNA ploidy, chromosome 11q status, and MYCN status as important parameters to consider for patient risk stratification (Cohn et al., 2009).